Cradle: experimental results shape the next protein-design round
Mechanism and classification
Sequence and target properties plus measured assay results → updated project model and next candidate selection. Interpret this mechanism at the stated maturity level. A launch, demonstration or reference blueprint does not establish widespread operation or commercial success.
Editorial scope
The status describes the documented stage of the model; it is not a claim of market penetration or commercial success. Provider metrics remain provider claims unless independently confirmed.
Evidence
- Source 1 · cradle.bio ↗Undated; geprüft 15.11.2026
- Source 2 · independence must be assessed separately · cradle.bio ↗30.07.2024
Complete research dossier
The complete editorial record — including the case-specific mechanism, chronology, limitations and cross-references — is maintained in German. Use the DE switch to open the exact counterpart.
Mechanism and limits
Researchers define objectives, test selected variants and upload results that inform subsequent model updates and candidate rounds. An in-silico ranking is distinct from a confirmed laboratory result.
The selected detail sources are provider-controlled. General speed and cost benefits, clinical efficacy, safety and industrial scalability are not independently established or inferred from a laboratory metric.
In the EU Frontier provider index
Cradle is listed by EU Frontier as a company. This directory reference adds provider identity context; it is not additional evidence of impact or operation for this Atlas entry.
Dates and evidence scope
- Recorded event / reference date
- 2024-11-26 (datierter Plattformbericht; kein behaupteter Erststart)
- Atlas first publication
- 2026-11-15
- Source review in this audit
- 2026-11-15
The editorial update date is not a claim that every source or current product feature was rechecked. Unknown dates remain open. Source publication dates are listed with the evidence above.
Structured evidence and geography register · Unclassified source roles and unassigned origin/market fields are explicitly marked.